Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jazz Pharmaceuticals plc (JAZZ)
USD236.97
-6.85 (-2.81%)
IE NASDAQ Healthcare Biotechnology
Address
Waterloo Exchange D04 E5W7
Dublin, IE
Dublin, IE
CEO
Renee D. Gala
Website
jazzpharma.com
IPO
2007-06-01
CIK 1232524 ISIN IE00B4Q5ZN47
Description
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Modeyso for the treatment of diffuse midline glioma harboring an H3 K27M mutation; and Defitelio to treat severe veno-occlusive disease. It also develops Zanidatamab in Phase 3 trial to treat HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancers (BTC); Dordaviprone to treat H3 K27M-mutant diffuse glioma; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. In addition, the company is developing Zanidatamab to treat neoadjuvant and adjuvant breast cancer; Vyxeos for the treatment of High-risk MDS, newly diagnosed untreated patients with high-risk AML, and De novo intermediate or adverse risk AML stratified by genomics; and JZP3507 to treat pheochromocytoma and paraganglioma that are in Phase 2 clinical trials. Further, it develops JZP815 to treat Raf and Ras mutant tumors; JZP898 for the IFN INDUKIN molecule in solid tumors; and JZP047 to treat absence epilepsy that are in Phase 1 clinical trials. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD236.97
-6.85 (-2.81%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
946.8K
Beta
0.33
Float Shares
59.44M
Free Float %
94.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.97% | -0.35% | +15.14% | +34.47% | +63.57% | +31.54% | +115.88% | +64.76% | +27.12% | +53.97% | +1,161.20% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (48 ratings, all time)
Buy
Price Targets & DCF
Current price
236.97
Low
188.00
-20.7%
Consensus
225.75
-4.7%
Median
234.50
-1.0%
High
252.00
+6.3%
DCF (Unlevered)
530.19
+123.7%
DCF (Levered)
790.87
+233.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
88% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 6 | 0 |
| Buy | 9 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
226.00
-4.6%
|
| Last Quarter | 3 |
225.33
-4.9%
|
| Last Year | 16 |
196.63
-17.0%
|
| All Time | 40 |
197.58
-16.6%
|
Quality scores
Altman Z-Score
1.84
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
2 / 5
Medium
ROA Score
3 / 5
Medium
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+4.9% ★ Q1'26: +19.1% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-167.5% Q1'26: +391.4% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+3.4% Q1'26: +36.3% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-10.2% Q1'26: +20.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-5.9% ★ Q1'26: +11.8% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%-7.6% ★ Q1'26: +8.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×50.01× Q1'26: 3.43× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 13 Rev. Ana. 10 EPS Ana. |
Dec 2027 13 Rev. Ana. 10 EPS Ana. |
Dec 2028 14 Rev. Ana. 5 EPS Ana. |
Dec 2029 9 Rev. Ana. 1 EPS Ana. |
Dec 2030 13 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
272.28M
est: 262.50M (+3.7%)
|
585.98M
est: 564.33M (+3.8%)
|
872.42M
est: 876.62M (-0.5%)
|
1.17B
est: 1.15B (+2.1%)
|
1.32B
est: 1.34B (-0.8%)
|
1.49B
est: 1.49B (-0.1%)
|
1.62B
est: 1.62B (-0.3%)
|
1.89B
est: 1.88B (+0.8%)
|
2.16B
est: 2.14B (+1.0%)
|
2.36B
est: 2.33B (+1.4%)
|
3.09B
est: 3.06B (+1.0%)
|
3.66B
est: 3.66B (+0.0%)
|
3.83B
est: 3.84B (-0.2%)
|
4.07B
est: 4.04B (+0.7%)
|
4.27B
est: 4.24B (+0.7%)
|
4.50B
4.44B – 4.55B
+6.2% YoY
|
4.82B
4.68B – 5.03B
+7.2% YoY
|
5.25B
5.24B – 5.25B
+8.8% YoY
|
5.82B
5.64B – 6.01B
+10.9% YoY
|
6.08B
5.89B – 6.28B
+4.4% YoY
|
| EBITDA |
134.41M
est: 129.38M (+3.9%)
|
310.18M
est: 282.41M (+9.8%)
|
454.11M
est: 417.05M (+8.9%)
|
583.70M
est: 313.36M (+86.3%)
|
665.97M
est: 614.22M (+8.4%)
|
753.88M
est: 720.88M (+4.6%)
|
779.00M
est: 841.35M (-7.4%)
|
932.67M
est: 727.57M (+28.2%)
|
1.01B
est: 781.07M (+29.6%)
|
1.04B
est: 555.36M (+87.9%)
|
1.03B
est: 1.18B (-12.9%)
|
1.47B
est: 970.93M (+51.3%)
|
1.45B
est: 1.16B (+24.8%)
|
1.52B
est: 1.22B (+24.7%)
|
108.46M
est: 1.28B (-91.5%)
|
1.36B
1.34B – 1.37B
+6.2% YoY
|
1.46B
1.41B – 1.52B
+7.2% YoY
|
1.59B
1.58B – 1.59B
+8.8% YoY
|
1.76B
1.71B – 1.82B
+10.9% YoY
|
1.84B
1.78B – 1.90B
+4.4% YoY
|
| EBIT |
126.58M
est: 122.99M (+2.9%)
|
235.95M
est: 183.24M (+28.8%)
|
372.02M
est: 340.43M (+9.3%)
|
450.02M
est: 173.07M (+160.0%)
|
557.92M
est: 518.96M (+7.5%)
|
640.10M
est: 602.86M (+6.2%)
|
613.84M
est: 533.54M (+15.1%)
|
715.93M
est: 543.41M (+31.7%)
|
642.35M
est: 460.38M (+39.5%)
|
765.46M
est: 274.77M (+178.6%)
|
475.26M
est: 692.08M (-31.3%)
|
839.14M
est: 421.90M (+98.9%)
|
810.73M
est: 541.55M (+49.7%)
|
861.64M
est: 569.12M (+51.4%)
|
-433.54M
est: 597.10M (-172.6%)
|
633.93M
625.41M – 641.04M
+6.2% YoY
|
679.31M
659.79M – 708.61M
+7.2% YoY
|
739.36M
738.78M – 739.94M
+8.8% YoY
|
820.19M
795.18M – 847.15M
+10.9% YoY
|
856.18M
830.08M – 884.32M
+4.4% YoY
|
| Net Income |
124.98M
est: 120.22M (+4.0%)
|
288.59M
est: 270.47M (+6.7%)
|
216.31M
est: 215.05M (+0.6%)
|
58.39M
est: 39.87M (+46.4%)
|
329.54M
est: 336.24M (-2.0%)
|
396.83M
est: 411.55M (-3.6%)
|
487.85M
est: 491.29M (-0.7%)
|
447.10M
est: 391.91M (+14.1%)
|
523.37M
est: 454.81M (+15.1%)
|
238.62M
est: 162.64M (+46.7%)
|
-328.95M
est: 1.03B (-131.8%)
|
-224.06M
est: 177.38M (-226.3%)
|
414.83M
est: 330.79M (+25.4%)
|
560.12M
est: 1.23B (-54.5%)
|
-356.15M
est: 517.77M (-168.8%)
|
1.53B
1.41B – 1.65B
+195.7% YoY
|
1.62B
1.43B – 1.80B
+5.5% YoY
|
1.36B
1.17B – 2.46B
-16.0% YoY
|
1.95B
1.87B – 2.03B
+43.4% YoY
|
2.03B
1.95B – 2.12B
+4.3% YoY
|
| SGA |
108.94M
est: 104.73M (+4.0%)
|
223.88M
est: 220.34M (+1.6%)
|
304.30M
est: 305.65M (-0.4%)
|
406.11M
est: 398.93M (+1.8%)
|
449.12M
est: 459.11M (-2.2%)
|
502.89M
est: 512.15M (-1.8%)
|
544.16M
est: 542.37M (+0.3%)
|
683.53M
est: 610.42M (+12.0%)
|
736.94M
est: 645.75M (+14.1%)
|
854.23M
est: 885.82M (-3.6%)
|
1.45B
est: 1.17B (+24.2%)
|
1.42B
est: 1.24B (+14.1%)
|
1.34B
est: 1.52B (-11.4%)
|
1.39B
est: 1.59B (-13.0%)
|
1.81B
est: 1.67B (+8.3%)
|
1.77B
1.75B – 1.79B
+6.2% YoY
|
1.90B
1.85B – 1.98B
+7.2% YoY
|
2.07B
2.07B – 2.07B
+8.8% YoY
|
2.29B
2.22B – 2.37B
+10.9% YoY
|
2.40B
2.32B – 2.47B
+4.4% YoY
|
| EPS |
3.01
est: 3.26 (-7.7%)
|
5.09
est: 4.44 (+14.6%)
|
3.71
est: 6.34 (-41.5%)
|
0.98
est: 8.03 (-87.8%)
|
5.38
est: 9.52 (-43.5%)
|
6.56
est: 10.03 (-34.6%)
|
8.13
est: 11.06 (-26.5%)
|
7.45
est: 13.08 (-43.1%)
|
9.22
est: 15.90 (-42.0%)
|
4.28
est: 12.60 (-66.0%)
|
-5.51
est: 15.67 (-135.2%)
|
-3.58
est: 13.56 (-126.4%)
|
6.55
est: 5.25 (+24.8%)
|
9.06
est: 20.31 (-55.4%)
|
-5.84
est: 8.23 (-171.0%)
|
25.12
23.10 – 27.12
+205.3% YoY
|
25.64
23.43 – 29.54
+2.1% YoY
|
28.82
19.20 – 40.30
+12.4% YoY
|
31.91
30.65 – 33.28
+10.7% YoY
|
33.27
31.95 – 34.69
+4.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-22 | Leerink Partners | Outperform | Outperform | Maintain |
| 2026-04-20 | Barclays | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 2/5 | 4/5 | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | B- | 3/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.28B
OE per share TTM
20.33
Owner's Yield
9.71%
Maintenance CapEx ratio
2.01%
Maint CapEx / Avg PPE
8.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
136
Total invested
757.83M
Insider transactions (90d)
1
Beneficial owners (>5%)
8
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Edward C. Johnson 3d | 9.09M | 15.00% | — | — | 9.09M | — | IN | United States of America | 2015-02-13 | ↗ |
| 2 | The Vanguard Group - 23-1945930 | 5.54M | 9.02% | — | 56.3K | 5.41M | 130.6K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 3 | 26-4376599 | 5.24M | 8.70% | — | — | 5.24M | — | IV | Massachusetts | 2018-02-07 | ↗ |
| 4 | JPMORGAN CHASE & CO.13-2624428 | 3.25M | 5.20% | 3.03M | — | 3.25M | 226.00 | HC | Delaware | 2022-01-24 | ↗ |
| 5 | 04-3542621 | 3.10M | 5.10% | 4.7K | — | 3.10M | — | IA | Delaware | 2019-02-14 | ↗ |
| 6 | Abigail P. Johnson | 1.70M | 2.76% | — | — | 1.70M | — | IN | United States of America | 2022-02-09 | ↗ |
| 7 | FMR LLC | 1.70M | 2.76% | 208.9K | — | 1.70M | — | HC | Delaware | 2022-02-09 | ↗ |
| 8 | 13-3127734 | 1.70M | 2.77% | 1.70M | — | 1.70M | — | HC | Delaware | 2022-02-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
136
-457 vs prev Q
New positions
26
Closed positions
464
Increased
69
Reduced
44
Put/Call ratio
0.00
Calls held
—
Puts held
53.0K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 5.92M +10.2K (+0.2%) | 1.01B +227.4M (+29.2%) | 9.75% +0.096 pp | 0.01% +0.003 pp | USD112.53 +51.1% | 56 qtrs — |
| 2 | BLACKROCK, INC. | 5.45M -108.1K (-1.9%) | 926.71M +194.0M (+26.5%) | 8.98% -0.104 pp | 0.02% +0.003 pp | USD111.38 +52.6% | 6 qtrs — |
| 3 | CAPITAL WORLD INVESTORS | 2.67M +111.7K (+4.4%) | 453.32M +116.6M (+34.6%) | 4.39% +0.218 pp | 0.06% +0.016 pp | USD115.86 +46.7% | 8 qtrs — |
| 4 | DIMENSIONAL FUND ADVISORS LP | 2.62M -213.3K (-7.5%) | 445.96M +72.1M (+19.3%) | 4.32% -0.314 pp | 0.09% +0.013 pp | USD121.10 +40.4% | 51 qtrs — |
| 5 | LSV ASSET MANAGEMENT | 2.46M -55.9K (-2.2%) | 417.51M +86.5M (+26.1%) | 4.05% -0.058 pp | 0.91% +0.179 pp | USD134.54 +26.4% | 35 qtrs — |
| 6 | STATE STREET CORP | 1.84M -30.1K (-1.6%) | 312.42M +66.2M (+26.9%) | 3.03% -0.025 pp | 0.01% +0.002 pp | USD140.69 +20.8% | 51 qtrs — |
| 7 | FRANKLIN RESOURCES INC | 1.82M +1.1M (+164.0%) | 309.21M +218.4M (+240.5%) | 3.00% +1.871 pp | 0.08% +0.053 pp | USD160.13 +6.2% | 51 qtrs — |
| 8 | ECOR1 CAPITAL, LLC | 1.71M +— (+0.0%) | 290.10M +65.2M (+29.0%) | 2.81% +0.023 pp | 13.16% +2.369 pp | USD118.51 +43.4% | 11 qtrs — |
| 9 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.68M +51.0K (+3.1%) | 285.11M +70.8M (+33.0%) | 2.76% +0.106 pp | 0.96% +0.235 pp | USD120.71 +40.8% | 8 qtrs — |
| 10 | AMERIPRISE FINANCIAL INC | 1.52M -326.4K (-17.7%) | 258.59M +15.1M (+6.2%) | 2.51% -0.513 pp | 0.06% +0.003 pp | USD132.28 +28.5% | 56 qtrs — |
| 11 | MILLENNIUM MANAGEMENT LLC | 1.20M +933.6K (+346.9%) | 204.46M +169.0M (+476.5%) | 1.98% +1.542 pp | 0.09% +0.071 pp | USD155.73 +9.2% | 56 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.20M +1.2K (+0.1%) | 203.57M +45.9M (+29.1%) | 1.97% +0.018 pp | 0.01% +0.003 pp | USD133.45 +27.4% | 56 qtrs — |
| 13 | BANK OF NEW YORK MELLON CORP | 1.16M +715.4K (+160.2%) | 197.52M +138.7M (+235.6%) | 1.91% +1.185 pp | 0.04% +0.024 pp | USD159.09 +6.9% | 56 qtrs — |
| 14 | SWEDBANK AB | 1.10M +28.9K (+2.7%) | 187.51M +45.9M (+32.5%) | 1.82% +0.062 pp | 0.18% +0.038 pp | USD109.70 +55.0% | 20 qtrs — |
| 15 | JPMORGAN CHASE & CO | 1.04M -822.5K (-44.1%) | 177.59M -68.5M (-27.8%) | 1.72% -1.330 pp | 0.01% -0.004 pp | USD144.15 +17.9% | 51 qtrs — |
| 16 | SOFINNOVA INVESTMENTS, INC. | 959.9K +371.0K (+63.0%) | 163.18M +85.6M (+110.3%) | 1.58% +0.619 pp | 7.04% +2.792 pp | USD136.54 +24.5% | 6 qtrs — |
| 17 | BANK OF AMERICA CORP /DE/ | 915.1K -52.8K (-5.5%) | 155.57M +28.0M (+22.0%) | 1.51% -0.074 pp | 0.01% +0.003 pp | USD127.61 +33.2% | 52 qtrs — |
| 18 | AQR CAPITAL MANAGEMENT LLC | 877.3K +178.3K (+25.5%) | 149.14M +58.2M (+64.0%) | 1.45% +0.303 pp | 0.08% +0.020 pp | USD128.75 +32.0% | 14 qtrs — |
| 19 | RENAISSANCE TECHNOLOGIES LLC | 836.8K -88.1K (-9.5%) | 142.25M +20.4M (+16.7%) | 1.38% -0.133 pp | 0.22% +0.060 pp | USD134.46 +26.4% | 43 qtrs — |
| 20 | FMR LLC | 800.9K +118.8K (+17.4%) | 136.16M +46.3M (+51.4%) | 1.32% +0.205 pp | 0.01% +0.002 pp | USD140.42 +21.1% | 56 qtrs — |
| 21 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 706.0K +148.6K (+26.7%) | 120.03M +46.6M (+63.4%) | 1.16% +0.252 pp | 0.14% -0.053 pp | USD143.95 +18.1% | 43 qtrs — |
| 22 | PACER ADVISORS, INC. | 647.1K +107.1K (+19.8%) | 110.00M +38.8M (+54.6%) | 1.07% +0.184 pp | 0.28% +0.102 pp | USD132.07 +28.7% | 14 qtrs — |
| 23 | MORGAN STANLEY | 639.2K -78.4K (-10.9%) | 108.66M +14.1M (+14.9%) | 1.05% -0.120 pp | 0.01% +0.001 pp | USD133.40 +27.4% | 51 qtrs — |
| 24 | GMT CAPITAL CORP | 638.5K -154.3K (-19.5%) | 108.55M +4.1M (+3.9%) | 1.05% -0.244 pp | 5.66% +0.922 pp | USD118.43 +43.5% | 6 qtrs — |
| 25 | ALLIANZ ASSET MANAGEMENT GMBH | 598.8K +242.9K (+68.2%) | 101.80M +54.9M (+117.0%) | 0.99% +0.405 pp | 0.10% +0.051 pp | USD135.05 +25.9% | 51 qtrs — |
| 26 | HOLOCENE ADVISORS, LP | 589.7K -15.4K (-2.5%) | 100.25M +20.5M (+25.7%) | 0.97% -0.017 pp | 0.21% +0.029 pp | USD125.86 +35.1% | 4 qtrs — |
| 27 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 548.0K +395.0K (+258.2%) | 93.16M +73.0M (+362.0%) | 0.90% +0.653 pp | 0.14% +0.109 pp | USD153.43 +10.8% | 4 qtrs — |
| 28 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 547.7K +31.4K (+6.1%) | 93.12M +25.1M (+36.8%) | 0.90% +0.059 pp | 0.08% +0.021 pp | USD129.34 +31.4% | 22 qtrs — |
| 29 | QUBE RESEARCH & TECHNOLOGIES LTD | 500.5K +444.2K (+789.8%) | 85.08M +77.7M (+1,047.8%) | 0.82% +0.733 pp | 0.09% +0.079 pp | USD164.62 +3.3% | 14 qtrs — |
| 30 | NORTHERN TRUST CORP | 476.9K -26.7K (-5.3%) | 81.07M +14.7M (+22.1%) | 0.79% -0.037 pp | 0.01% +0.002 pp | USD139.58 +21.8% | 51 qtrs — |
| 31 | UBS GROUP AG | 473.0K +18.5K (+4.1%) | 80.40M +20.5M (+34.2%) | 0.78% +0.037 pp | 0.01% +0.004 pp | USD132.10 +28.7% | 45 qtrs — |
| 32 | POLARIS CAPITAL MANAGEMENT, LLC | 432.5K -81.0K (-15.8%) | 73.52M +5.8M (+8.6%) | 0.71% -0.127 pp | 6.10% +1.651 pp | USD155.28 +9.5% | 19 qtrs — |
| 33 | GW&K INVESTMENT MANAGEMENT, LLC | 427.6K -27.1K (-6.0%) | 72.70M +12.8M (+21.3%) | 0.70% -0.039 pp | 0.63% +0.098 pp | USD132.63 +28.2% | 29 qtrs — |
| 34 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 424.3K -43.2K (-9.2%) | 72.13M +10.5M (+17.1%) | 0.70% -0.065 pp | 0.01% +0.001 pp | USD137.95 +23.2% | 56 qtrs — |
| 35 | GOLDENTREE ASSET MANAGEMENT LP | 420.3K -716.8K (-63.0%) | 71.34M -78.3M (-52.3%) | 0.69% -1.166 pp | 3.87% -8.495 pp | USD131.80 +29.0% | 2 qtrs — |
| 36 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 396.9K +2.5K (+0.6%) | 67.47M +15.5M (+29.8%) | 0.65% +0.010 pp | 1.59% +0.327 pp | USD129.79 +31.0% | 32 qtrs — |
| 37 | BOSTON TRUST WALDEN CORP | 393.9K -14.9K (-3.6%) | 66.96M +13.1M (+24.3%) | 0.65% -0.019 pp | 0.51% +0.110 pp | USD114.03 +49.1% | 4 qtrs — |
| 38 | NUVEEN, LLC | 381.9K -6.8K (-1.7%) | 64.93M +13.7M (+26.7%) | 0.63% -0.006 pp | 0.02% +0.004 pp | USD124.15 +36.9% | 4 qtrs — |
| 39 | ALYESKA INVESTMENT GROUP, L.P. | 323.4K +117.4K (+57.0%) | 54.98M +27.8M (+102.5%) | 0.53% +0.196 pp | 0.16% +0.073 pp | USD129.48 +31.3% | 5 qtrs — |
| 40 | CITADEL ADVISORS LLC | 311.1K -572.8K (-64.8%) | 52.89M -63.6M (-54.6%) | 0.51% -0.932 pp | 0.01% -0.010 pp | USD119.15 +42.7% | 52 qtrs — |
| 41 | IRON TRIANGLE PARTNERS LP | 292.2K +142.2K (+94.8%) | 49.67M +29.9M (+151.2%) | 0.48% +0.236 pp | 5.68% +2.867 pp | USD150.39 +13.0% | 4 qtrs — |
| 42 | AMERICAN CENTURY COMPANIES INC | 291.4K +74.9K (+34.6%) | 49.53M +21.0M (+73.6%) | 0.48% +0.126 pp | 0.02% +0.010 pp | USD135.03 +25.9% | 51 qtrs — |
| 43 | THOMPSON SIEGEL & WALMSLEY LLC | 290.2K -83.7K (-22.4%) | 49.33M +51.0K (+0.1%) | 0.48% -0.133 pp | 0.83% +0.032 pp | USD119.10 +42.7% | 25 qtrs — |
| 44 | VESTAL POINT CAPITAL, LP | 290.0K -210.0K (-42.0%) | 49.30M -16.6M (-25.2%) | 0.48% -0.339 pp | 1.68% -1.300 pp | USD106.12 +60.2% | 9 qtrs — |
| 45 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 265.1K -11.8K (-4.3%) | 45.06M +8.6M (+23.5%) | 0.44% -0.016 pp | 0.08% +0.010 pp | USD114.83 +48.0% | 29 qtrs — |
| 46 | VICTORY CAPITAL MANAGEMENT INC | 249.7K -55.7K (-18.2%) | 42.45M +2.2M (+5.5%) | 0.41% -0.088 pp | 0.02% +0.000 pp | USD130.48 +30.3% | 45 qtrs — |
| 47 | SATURN V CAPITAL MANAGEMENT LLC | 248.1K -52.5K (-17.5%) | 42.17M +2.6M (+6.4%) | 0.41% -0.083 pp | 7.74% -0.950 pp | USD114.12 +49.0% | 3 qtrs — |
| 48 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 245.3K -87.5K (-26.3%) | 41.70M -2.2M (-4.9%) | 0.40% -0.140 pp | 0.00% 0.000 pp | USD124.74 +36.3% | 51 qtrs — |
| 49 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 228.6K +197.1K (+624.2%) | 38.87M +34.7M (+834.1%) | 0.38% +0.325 pp | 0.08% +0.074 pp | USD163.75 +3.8% | 55 qtrs — |
| 50 | BANK OF MONTREAL /CAN/ | 223.3K -113.8K (-33.8%) | 37.96M -6.5M (-14.6%) | 0.37% -0.183 pp | 0.01% -0.004 pp | USD114.65 +48.3% | 51 qtrs — |
| 51 | LOGOS GLOBAL MANAGEMENT LP | 200.0K +— (+0.0%) | 34.00M +7.6M (+29.0%) | 0.33% +0.003 pp | 2.05% -0.308 pp | USD106.12 +60.2% | 5 qtrs — |
| 52 | D. E. SHAW & CO., INC. | 199.3K +74.9K (+60.3%) | 33.88M +17.5M (+106.7%) | 0.33% +0.125 pp | 0.02% +0.009 pp | USD146.14 +16.3% | 13 qtrs — |
| 53 | INVESCO LTD. | 191.3K +20.1K (+11.7%) | 32.52M +10.0M (+44.1%) | 0.32% +0.035 pp | 0.01% +0.001 pp | USD132.45 +28.4% | 56 qtrs — |
| 54 | WEDGE CAPITAL MANAGEMENT L L P/NC | 188.9K -22.3K (-10.6%) | 32.11M +4.3M (+15.4%) | 0.31% -0.034 pp | 0.58% +0.105 pp | USD131.80 +29.0% | 6 qtrs — |
| 55 | PICTET ASSET MANAGEMENT HOLDING SA | 184.7K -33.5K (-15.4%) | 31.49M +3.3M (+11.7%) | 0.30% -0.052 pp | 0.03% +0.003 pp | USD126.43 +34.5% | 10 qtrs — |
| 56 | FRONTIER CAPITAL MANAGEMENT CO LLC | 182.2K +143.7K (+373.1%) | 30.97M +25.9M (+510.3%) | 0.30% +0.237 pp | 0.33% +0.283 pp | USD162.57 +4.6% | 15 qtrs — |
| 57 | RAYMOND JAMES FINANCIAL INC | 177.3K +18.5K (+11.6%) | 30.19M +9.2M (+44.2%) | 0.29% +0.033 pp | 0.01% +0.003 pp | USD128.01 +32.8% | 5 qtrs — |
| 58 | POINT72 ASSET MANAGEMENT, L.P. | 175.0K +163.1K (+1,376.2%) | 29.75M +28.2M (+1,803.9%) | 0.29% +0.269 pp | 0.03% +0.031 pp | USD167.41 +1.5% | 7 qtrs — |
| 59 | GOLDMAN SACHS GROUP INC | 174.5K +9.4K (+5.7%) | 29.66M +7.9M (+36.3%) | 0.29% +0.018 pp | 0.00% +0.001 pp | USD128.78 +32.0% | 56 qtrs — |
| 60 | QUANTINNO CAPITAL MANAGEMENT LP | 174.4K +137.5K (+372.6%) | 29.64M +24.8M (+509.6%) | 0.29% +0.227 pp | 0.06% +0.046 pp | USD159.11 +6.8% | 17 qtrs — |
| 61 | PERCEPTIVE ADVISORS LLC | 170.0K +170.0K (+100.0%) | 28.90M +28.9M (+100.0%) | 0.28% +0.280 pp | 0.52% +0.515 pp | USD170.00 +0.0% | 1 qtrs NEW |
| 62 | KRENSAVAGE ASSET MANAGEMENT, LLC | 167.8K +— (+0.0%) | 28.53M +6.4M (+29.0%) | 0.28% +0.002 pp | 10.08% +0.653 pp | USD115.90 +46.7% | 9 qtrs — |
| 63 | RETIREMENT SYSTEMS OF ALABAMA | 167.7K -20.7K (-11.0%) | 28.51M +3.7M (+14.8%) | 0.28% -0.032 pp | 0.09% +0.010 pp | USD149.39 +13.8% | 22 qtrs — |
| 64 | IKARIAN CAPITAL, LLC | 160.4K +82.6K (+106.1%) | 27.26M +17.0M (+165.9%) | 0.26% +0.137 pp | 2.13% +1.093 pp | USD145.06 +17.2% | 3 qtrs — |
| 65 | ARISTOTLE CAPITAL MANAGEMENT, LLC | 158.8K +781.0 (+0.5%) | 27.00M +6.2M (+29.6%) | 0.26% +0.003 pp | 0.05% +0.014 pp | USD126.80 +34.1% | 10 qtrs — |
| 66 | RHUMBLINE ADVISERS | 158.2K -6.4K (-3.9%) | 26.90M +5.2M (+23.9%) | 0.26% -0.008 pp | 0.02% +0.004 pp | USD149.32 +13.8% | 31 qtrs — |
| 67 | PERPETUAL LTD | 154.7K -448.0K (-74.3%) | 26.29M -53.1M (-66.9%) | 0.25% -0.730 pp | 0.38% -0.606 pp | USD121.03 +40.5% | 11 qtrs — |
| 68 | UBS ASSET MANAGEMENT AMERICAS INC | 148.3K -21.4K (-12.6%) | 25.21M +2.9M (+12.7%) | 0.24% -0.033 pp | 0.01% +0.001 pp | USD118.16 +43.9% | 56 qtrs — |
| 69 | DEUTSCHE BANK AG\ | 140.3K +124.9K (+809.6%) | 23.85M +21.8M (+1,073.3%) | 0.23% +0.206 pp | 0.01% +0.007 pp | USD166.28 +2.2% | 50 qtrs — |
| 70 | SCHONFELD STRATEGIC ADVISORS LLC | 139.2K -297.2K (-68.1%) | 23.67M -33.9M (-58.9%) | 0.23% -0.484 pp | 0.10% -0.222 pp | USD128.42 +32.4% | 6 qtrs — |
| 71 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 137.6K +116.5K (+554.8%) | 23.38M +20.6M (+744.5%) | 0.23% +0.192 pp | 0.18% +0.155 pp | USD163.00 +4.3% | 4 qtrs — |
| 72 | SG AMERICAS SECURITIES, LLC | 136.0K +131.6K (+2,969.1%) | 23.12M +22.5M (+3,859.6%) | 0.22% +0.217 pp | 0.03% +0.028 pp | USD168.56 +0.9% | 50 qtrs — |
| 73 | PRINCIPAL FINANCIAL GROUP INC | 130.6K -4.0K (-3.0%) | 22.20M +4.5M (+25.1%) | 0.22% -0.005 pp | 0.01% +0.002 pp | USD154.15 +10.3% | 31 qtrs — |
| 74 | SUMMITTX CAPITAL, L.P. | 126.8K +103.8K (+451.2%) | 21.56M +18.5M (+610.9%) | 0.21% +0.171 pp | 0.65% +0.524 pp | USD159.88 +6.3% | 4 qtrs — |
| 75 | STIFEL FINANCIAL CORP | 122.7K -3.2K (-2.5%) | 20.87M +4.3M (+25.7%) | 0.20% -0.004 pp | 0.02% +0.004 pp | USD125.34 +35.6% | 48 qtrs — |
| 76 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 119.0K -19.1K (-13.8%) | 20.23M +2.0M (+11.1%) | 0.20% -0.030 pp | 0.06% +0.004 pp | USD130.07 +30.7% | 18 qtrs — |
| 77 | LOOMIS SAYLES & CO L P | 116.4K -11.5K (-9.0%) | 19.80M +2.9M (+17.4%) | 0.19% -0.017 pp | 0.02% +0.004 pp | USD130.82 +29.9% | 28 qtrs — |
| 78 | WALLEYE CAPITAL LLC | 115.8K +33.0K (+39.8%) | 19.68M +8.8M (+80.3%) | 0.19% +0.055 pp | 0.06% +0.019 pp | USD142.68 +19.1% | 2 qtrs — |
| 79 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 112.7K -82.1K (-42.2%) | 19.15M -6.5M (-25.4%) | 0.19% -0.133 pp | 0.01% -0.004 pp | USD124.05 +37.0% | 53 qtrs — |
| 80 | WELLINGTON MANAGEMENT GROUP LLP | 112.6K -16.6K (-12.9%) | 19.14M +2.1M (+12.4%) | 0.19% -0.026 pp | 0.00% +0.000 pp | USD131.62 +29.2% | 34 qtrs — |
| 81 | SEI INVESTMENTS CO | 110.4K +10.1K (+10.1%) | 18.77M +5.6M (+42.0%) | 0.18% +0.018 pp | 0.02% +0.004 pp | USD129.05 +31.7% | 45 qtrs — |
| 82 | DISTILLATE CAPITAL PARTNERS LLC | 109.8K -1.6K (-1.4%) | 18.67M +4.0M (+27.2%) | 0.18% -0.001 pp | 0.96% +0.200 pp | USD108.07 +57.3% | 7 qtrs — |
| 83 | SWISS NATIONAL BANK | 107.7K -3.7K (-3.3%) | 18.31M +3.6M (+24.7%) | 0.18% -0.005 pp | 0.01% +0.002 pp | USD137.20 +23.9% | 51 qtrs — |
| 84 | ESTUARY CAPITAL MANAGEMENT LP | 106.4K -256.8K (-70.7%) | 18.09M -29.8M (-62.2%) | 0.18% -0.418 pp | 3.22% -5.283 pp | USD115.81 +46.8% | 9 qtrs — |
| 85 | DIADEMA PARTNERS LP | 105.3K +5.3K (+5.3%) | 17.90M +4.7M (+35.8%) | 0.17% +0.010 pp | 3.08% -0.288 pp | USD130.09 +30.7% | 4 qtrs — |
| 86 | KBC GROUP NV | 103.3K +7.1K (+7.3%) | 17.57M +4.9M (+38.4%) | 0.17% +0.013 pp | 0.04% +0.010 pp | USD122.46 +38.8% | 50 qtrs — |
| 87 | CANADA PENSION PLAN INVESTMENT BOARD | 102.8K +16.1K (+18.6%) | 17.48M +6.0M (+52.9%) | 0.17% +0.028 pp | 0.01% +0.004 pp | USD128.40 +32.4% | 20 qtrs — |
| 88 | ENGINEERS GATE MANAGER LP | 100.8K +100.8K (+100.0%) | 17.14M +17.1M (+100.0%) | 0.17% +0.166 pp | 0.20% +0.203 pp | USD170.00 +0.0% | 17 qtrs — |
| 89 | WELLS FARGO & COMPANY/MN | 100.5K +13.7K (+15.8%) | 17.09M +5.6M (+49.4%) | 0.17% +0.024 pp | 0.00% +0.001 pp | USD134.08 +26.8% | 56 qtrs — |
| 90 | ALLIANCEBERNSTEIN L.P. | 96.4K -30.9K (-24.3%) | 16.38M -389.6K (-2.3%) | 0.16% -0.049 pp | 0.01% 0.000 pp | USD132.14 +28.7% | 56 qtrs — |
| 91 | LEGAL & GENERAL GROUP PLC | 95.9K -24.0K (-20.0%) | 16.30M +498.3K (+3.2%) | 0.16% -0.038 pp | 0.00% +0.000 pp | USD125.75 +35.2% | 37 qtrs — |
| 92 | BARCLAYS PLC | 95.3K +56.1K (+143.1%) | 16.20M +11.8M (+270.9%) | 0.16% +0.093 pp | 0.00% +0.003 pp | USD154.63 +9.9% | 51 qtrs — |
| 93 | PANAGORA ASSET MANAGEMENT INC | 93.8K +92.3K (+6,026.8%) | 15.95M +15.7M (+7,802.6%) | 0.15% +0.152 pp | 0.06% +0.056 pp | USD169.25 +0.4% | 40 qtrs — |
| 94 | ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 93.6K -2.8K (-2.9%) | 15.92M +3.2M (+25.3%) | 0.15% -0.003 pp | 0.02% +0.004 pp | USD127.87 +32.9% | 33 qtrs — |
| 95 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 90.1K +25.0K (+38.4%) | 15.32M +6.7M (+78.5%) | 0.15% +0.042 pp | 0.02% +0.011 pp | USD136.87 +24.2% | 4 qtrs — |
| 96 | LOS ANGELES CAPITAL MANAGEMENT LLC | 109.9K -14.8K (-11.9%) | 14.98M -1.5M (-8.9%) | 0.18% -0.023 pp | 0.05% -0.005 pp | USD131.80 +29.0% | 27 qtrs — |
| 97 | ENVESTNET ASSET MANAGEMENT INC | 88.1K -14.1K (-13.8%) | 14.98M +1.5M (+11.2%) | 0.15% -0.022 pp | 0.00% +0.001 pp | USD131.36 +29.4% | 51 qtrs — |
| 98 | DEKABANK DEUTSCHE GIROZENTRALE | 115.1K +— (+0.0%) | 14.04M -649.0K (-4.4%) | 0.19% +0.002 pp | 0.02% -0.001 pp | USD124.66 +36.4% | 55 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
3
Shares acquired
—
Shares disposed
6.0K
Cash buys
—
Cash sales
3.00
Net activity
-6,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | COZADD BRUCE C | Director | S-Sale | D | Ordinary Shares | 6,000 | 203.33 | 1.22M | 378,682 | D | ↗ |
| 2026-04-01 | COZADD BRUCE C | Director | S-Sale | D | Ordinary Shares | 3,684 | 190.22 | 700.8K | 386,998 | D | ↗ |
| 2026-03-09 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 1,287 | 182.94 | 235.4K | 6,512 | D | ↗ |
| 2026-03-05 | Pearce Samantha | Officer | F-InKind | D | Ordinary Shares | 2,503 | 188.69 | 472.3K | 50,272 | D | ↗ |
| 2026-03-05 | Patil Neena M | Officer | F-InKind | D | Ordinary Shares | 5,000 | 188.69 | 943.5K | 53,818 | D | ↗ |
| 2026-03-05 | Johnson Philip L | Officer | F-InKind | D | Ordinary Shares | 2,615 | 188.69 | 493.4K | 59,608 | D | ↗ |
| 2026-03-05 | Iannone Robert | Officer | F-InKind | D | Ordinary Shares | 6,209 | 188.69 | 1.17M | 88,871 | D | ↗ |
| 2026-03-05 | Henderson Mary Elizabeth | Officer | F-InKind | D | Ordinary Shares | 1,394 | 186.75 | 260.3K | 27,334 | D | ↗ |
| 2026-03-05 | GALA RENEE D | Officer | F-InKind | D | Ordinary Shares | 7,065 | 188.69 | 1.33M | 152,630 | D | ↗ |
| 2026-03-05 | Carr Patricia | Officer | F-InKind | D | Ordinary Shares | 1,436 | 186.77 | 268.2K | 7,799 | D | ↗ |
| 2026-03-05 | COZADD BRUCE C | Director | F-InKind | D | Ordinary Shares | 15,114 | 188.69 | 2.85M | 390,682 | D | ↗ |
| 2026-03-03 | COZADD BRUCE C | Director | S-Sale | D | Ordinary Shares | 3,159 | 186.09 | 587.8K | 408,637 | D | ↗ |
| 2026-02-27 | RIEDEL NORBERT G | Director | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 3,415 | 138.08 | 471.5K | 0 | D | ↗ |
| 2026-02-27 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 1,117 | 190.91 | 213.2K | 9,235 | D | ↗ |
| 2026-02-26 | Pearce Samantha | Officer | A-Award | A | Ordinary Shares | 9,782 | 0.00 | — | 52,775 | D | ↗ |
| 2026-02-26 | Patil Neena M | Officer | M-Exempt | D | Incentive Stock Option (right to buy) | 2,916 | 137.12 | 399.8K | 0 | D | ↗ |
| 2026-02-26 | LOVE TED W | Director | A-Award | A | Ordinary Shares | 1,527 | 0.00 | — | 1,527 | D | ↗ |
| 2026-02-26 | Johnson Philip L | Officer | A-Award | A | Ordinary Shares | 11,857 | 0.00 | — | 62,223 | D | ↗ |
| 2026-02-26 | Iannone Robert | Officer | A-Award | A | Ordinary Shares | 14,822 | 0.00 | — | 95,080 | D | ↗ |
| 2026-02-26 | Henderson Mary Elizabeth | Officer | S-Sale | D | Ordinary Shares | 5,343 | 194.49 | 1.04M | 28,728 | D | ↗ |
| 2026-02-26 | GALA RENEE D | Officer | A-Award | A | Ordinary Shares | 44,465 | 0.00 | — | 159,695 | D | ↗ |
| 2026-02-26 | Carr Patricia | Officer | A-Award | A | Ordinary Shares | 2,223 | 0.00 | — | 11,605 | D | ↗ |
| 2026-01-16 | Pearce Samantha | Officer | F-InKind | D | Ordinary Shares | 1,599 | 171.16 | 273.7K | 42,993 | D | ↗ |
| 2026-01-16 | Patil Neena M | Officer | A-Award | A | Ordinary Shares | 8,852 | 0.00 | — | 56,614 | D | ↗ |
| 2026-01-16 | Iannone Robert | Officer | F-InKind | D | Ordinary Shares | 4,140 | 171.16 | 708.6K | 80,258 | D | ↗ |
| 2026-01-16 | Henderson Mary Elizabeth | Officer | A-Award | A | Ordinary Shares | 10,116 | 0.00 | — | 29,624 | D | ↗ |
| 2026-01-16 | GALA RENEE D | Officer | F-InKind | D | Ordinary Shares | 5,371 | 171.16 | 919.3K | 115,230 | D | ↗ |
| 2026-01-16 | Carr Patricia | Officer | A-Award | A | Ordinary Shares | 2,370 | 0.00 | — | 9,382 | D | ↗ |
| 2026-01-16 | COZADD BRUCE C | Director | A-Award | A | Ordinary Shares | 35,917 | 0.00 | — | 429,249 | D | ↗ |
| 2025-12-09 | Henderson Mary Elizabeth | Officer | S-Sale | D | Ordinary Shares | 2,238 | 169.51 | 379.4K | 19,508 | D | ↗ |
| 2025-12-05 | GALA RENEE D | Officer | F-InKind | D | Ordinary Shares | 80 | 166.91 | 13.4K | 107,860 | D | ↗ |
| 2025-12-05 | Carr Patricia | Officer | M-Exempt | A | Ordinary Shares | 4,500 | 140.67 | 633.0K | 11,512 | D | ↗ |
| 2025-12-02 | O'Keefe Kenneth W | Director | F-InKind | D | Ordinary Shares | 603 | 173.07 | 104.4K | 25,811 | D | ↗ |
| 2025-12-01 | LOVE TED W | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-11-26 | COZADD BRUCE C | Director | S-Sale | D | Ordinary Shares | 8,380 | 179.23 | 1.50M | 431,965 | D | ↗ |
| 2025-11-20 | McSharry Heather Ann | Director | M-Exempt | A | Ordinary Shares | 3,415 | 138.08 | 471.5K | 23,864 | D | ↗ |
| 2025-11-20 | COZADD BRUCE C | Director | A-Award | A | Ordinary Shares | 2,506 | 0.00 | — | 393,332 | D | ↗ |
| 2025-11-19 | Henderson Mary Elizabeth | Officer | D-Return | D | Ordinary Shares | 1,331 | 180.40 | 240.1K | 21,746 | D | ↗ |
| 2025-11-18 | Winningham Rick E | Director | S-Sale | D | Ordinary Shares | 5,500 | 180.86 | 994.7K | 8,893 | D | ↗ |
| 2025-11-18 | Carr Patricia | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 5,250 | 136.18 | 714.9K | 0 | D | ↗ |
| 2025-11-18 | COZADD BRUCE C | Director | S-Sale | D | Ordinary Shares | 717 | 182.60 | 130.9K | 390,826 | D | ↗ |
| 2025-11-17 | Iannone Robert | Officer | S-Sale | D | Ordinary Shares | 7,159 | 168.26 | 1.20M | 72,628 | D | ↗ |
| 2025-10-03 | COZADD BRUCE C | Director | S-Sale | D | Ordinary Shares | 3,500 | 140.00 | 490.0K | 408,826 | D | ↗ |
| 2025-10-01 | COZADD BRUCE C | Director | S-Sale | D | Ordinary Shares | 2,000 | 131.78 | 263.6K | 412,326 | D | ↗ |
| 2025-09-14 | COZADD BRUCE C | Director | F-InKind | D | Ordinary Shares | 15,647 | 126.16 | 1.97M | 414,326 | D | ↗ |
| 2025-09-02 | COZADD BRUCE C | Director | S-Sale | D | Ordinary Shares | 3,000 | 127.23 | 381.7K | 432,973 | D | ↗ |
| 2025-08-18 | ENRIGHT PATRICK G | Director | J-Other | D | Ordinary Shares | 5,000 | 0.00 | — | 21,379 | D | ↗ |
| 2025-08-08 | Winningham Rick E | Director | F-InKind | D | Ordinary Shares | 1,805 | 111.25 | 200.8K | 14,393 | D | ↗ |
| 2025-08-08 | Smith Mark Douglas | Director | F-InKind | D | Ordinary Shares | 1,805 | 111.25 | 200.8K | 10,837 | D | ↗ |
| 2025-08-08 | RIEDEL NORBERT G | Director | F-InKind | D | Ordinary Shares | 1,805 | 111.25 | 200.8K | 7,024 | D | ↗ |
| 2025-08-08 | ORiordan Anne | Director | F-InKind | D | Ordinary Shares | 1,805 | 111.25 | 200.8K | 16,500 | D | ↗ |
| 2025-08-08 | O'Keefe Kenneth W | Director | F-InKind | D | Ordinary Shares | 1,805 | 111.25 | 200.8K | 28,672 | D | ↗ |
| 2025-08-08 | McSharry Heather Ann | Director | F-InKind | D | Ordinary Shares | 1,959 | 111.25 | 217.9K | 20,449 | D | ↗ |
| 2025-08-08 | Kennedy Patrick | Director | F-InKind | D | Ordinary Shares | 1,959 | 111.25 | 217.9K | 6,702 | D | ↗ |
| 2025-08-08 | Hamill Laura | Director | F-InKind | D | Ordinary Shares | 1,805 | 111.25 | 200.8K | 6,933 | D | ↗ |
| 2025-08-08 | ENRIGHT PATRICK G | Director | F-InKind | D | Ordinary Shares | 1,805 | 111.25 | 200.8K | 26,379 | D | ↗ |
| 2025-08-08 | Cook Jennifer E. | Director | F-InKind | D | Ordinary Shares | 1,805 | 111.25 | 200.8K | 10,837 | D | ↗ |
| 2025-08-07 | Winningham Rick E | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 16,198 | D | ↗ |
| 2025-08-07 | Smith Mark Douglas | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 12,642 | D | ↗ |
| 2025-08-07 | RIEDEL NORBERT G | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 8,829 | D | ↗ |
| 2025-08-07 | ORiordan Anne | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 18,305 | D | ↗ |
| 2025-08-07 | O'Keefe Kenneth W | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 30,477 | D | ↗ |
| 2025-08-07 | Mulligan Seamus | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 1,179,613 | D | ↗ |
| 2025-08-07 | McSharry Heather Ann | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 22,408 | D | ↗ |
| 2025-08-07 | Kennedy Patrick | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 8,661 | D | ↗ |
| 2025-08-07 | Hamill Laura | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 8,738 | D | ↗ |
| 2025-08-07 | GALA RENEE D | Officer | A-Award | A | Ordinary Shares | 18,808 | 0.00 | — | 107,869 | D | ↗ |
| 2025-08-07 | ENRIGHT PATRICK G | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 28,184 | D | ↗ |
| 2025-08-07 | Cook Jennifer E. | Director | A-Award | A | Ordinary Shares | 3,507 | 0.00 | — | 12,642 | D | ↗ |
| 2025-08-05 | Pearce Samantha | Officer | F-InKind | D | Ordinary Shares | 577 | 116.10 | 67.0K | 40,815 | D | ↗ |
| 2025-08-01 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 1,000 | 113.21 | 113.2K | 435,973 | D | ↗ |
| 2025-07-01 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 500 | 105.26 | 52.6K | 437,473 | D | ↗ |
| 2025-06-03 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 500 | 110.00 | 55.0K | 437,973 | D | ↗ |
| 2025-06-02 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 500 | 107.90 | 54.0K | 438,473 | D | ↗ |
| 2025-05-12 | Mulligan Seamus | Director | P-Purchase | A | Ordinary Shares | 1,621 | 103.00 | 167.0K | 101,621 | I | ↗ |
| 2025-05-09 | Mulligan Seamus | Director | P-Purchase | A | Ordinary Shares | 100 | 99.71 | 10.0K | 100,000 | I | ↗ |
| 2025-05-02 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 500 | 120.00 | 60.0K | 438,807 | D | ↗ |
| 2025-05-01 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 1,000 | 116.35 | 116.4K | 439,307 | D | ↗ |
| 2025-04-01 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 1,500 | 123.75 | 185.6K | 440,307 | D | ↗ |
| 2025-03-10 | Iannone Robert | Officer | S-Sale | D | Ordinary Shares | 2,403 | 138.41 | 332.6K | 79,621 | D | ↗ |
| 2025-03-10 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 1,140 | 137.81 | 157.1K | 7,012 | D | ↗ |
| 2025-03-07 | Iannone Robert | Officer | S-Sale | D | Ordinary Shares | 1,548 | 140.00 | 216.7K | 82,024 | D | ↗ |
| 2025-03-07 | Henderson Mary Elizabeth | Officer | D-Return | D | Ordinary Shares | 698 | 138.23 | 96.5K | 23,077 | D | ↗ |
| 2025-03-07 | Carr Patricia | Officer | D-Return | D | Ordinary Shares | 1,333 | 138.23 | 184.3K | 8,152 | D | ↗ |
| 2025-03-05 | Pearce Samantha | Officer | D-Return | D | Ordinary Shares | 1,905 | 138.95 | 264.7K | 41,226 | D | ↗ |
| 2025-03-05 | Patil Neena M | Officer | D-Return | D | Ordinary Shares | 4,088 | 138.95 | 568.0K | 47,526 | D | ↗ |
| 2025-03-05 | Johnson Philip L | Officer | D-Return | D | Ordinary Shares | 1,149 | 138.95 | 159.7K | 50,060 | D | ↗ |
| 2025-03-05 | Iannone Robert | Officer | D-Return | D | Ordinary Shares | 5,239 | 138.95 | 728.0K | 89,104 | D | ↗ |
| 2025-03-05 | GALA RENEE D | Officer | D-Return | D | Ordinary Shares | 5,704 | 138.95 | 792.6K | 88,895 | D | ↗ |
| 2025-03-05 | COZADD BRUCE C | Director / Officer | D-Return | D | Ordinary Shares | 22,251 | 138.95 | 3.09M | 441,807 | D | ↗ |
| 2025-03-03 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 6,500 | 144.25 | 937.6K | 464,058 | D | ↗ |
| 2025-02-28 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 773 | 143.30 | 110.8K | 9,485 | D | ↗ |
| 2025-02-27 | Pearce Samantha | Officer | A-Award | A | Ordinary Shares | 11,941 | 0.00 | — | 37,353 | D | ↗ |
| 2025-02-27 | Patil Neena M | Officer | S-Sale | D | Ordinary Shares | 3,800 | 144.87 | 550.5K | 33,318 | D | ↗ |
| 2025-02-27 | Johnson Philip L | Officer | A-Award | A | Ordinary Shares | 15,407 | 0.00 | — | 43,505 | D | ↗ |
| 2025-02-27 | Iannone Robert | Officer | A-Award | A | Ordinary Shares | 17,718 | 0.00 | — | 85,484 | D | ↗ |
| 2025-02-27 | Henderson Mary Elizabeth | Officer | A-Award | A | Ordinary Shares | 5,392 | 0.00 | — | 19,923 | D | ↗ |
| 2025-02-27 | GALA RENEE D | Officer | A-Award | A | Ordinary Shares | 23,111 | 0.00 | — | 83,044 | D | ↗ |
| 2025-02-27 | Carr Patricia | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 313 | 123.36 | 38.6K | 0 | D | ↗ |
| 2025-02-27 | COZADD BRUCE C | Director / Officer | A-Award | A | Ordinary Shares | 30,814 | 0.00 | — | 470,558 | D | ↗ |
| 2025-02-03 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 1,500 | 122.31 | 183.5K | 439,744 | D | ↗ |
| 2025-01-17 | Pearce Samantha | Officer | A-Award | A | Ordinary Shares | 2,533 | 0.00 | — | 26,777 | D | ↗ |
| 2025-01-17 | Patil Neena M | Officer | F-InKind | D | Ordinary Shares | 1,905 | 122.62 | 233.6K | 37,118 | D | ↗ |
| 2025-01-17 | Iannone Robert | Officer | F-InKind | D | Ordinary Shares | 2,181 | 122.62 | 267.4K | 67,766 | D | ↗ |
| 2025-01-17 | GALA RENEE D | Officer | F-InKind | D | Ordinary Shares | 3,300 | 122.62 | 404.6K | 59,933 | D | ↗ |
| 2025-01-17 | Carr Patricia | Officer | A-Award | A | Ordinary Shares | 1,641 | 0.00 | — | 8,237 | D | ↗ |
| 2025-01-17 | COZADD BRUCE C | Director / Officer | A-Award | A | Ordinary Shares | 29,559 | 0.00 | — | 455,084 | D | ↗ |
| 2025-01-02 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 1,500 | 123.43 | 185.1K | 425,525 | D | ↗ |
| 2024-12-05 | GALA RENEE D | Officer | F-InKind | D | Ordinary Shares | 80 | 123.45 | 9.9K | 55,492 | D | ↗ |
| 2024-12-02 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 53 | 122.49 | 6.5K | 6,596 | D | ↗ |
| 2024-12-02 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 2,000 | 121.17 | 242.3K | 427,025 | D | ↗ |
| 2024-11-08 | Patil Neena M | Officer | S-Sale | D | Ordinary Shares | 3,700 | 123.41 | 456.6K | 33,048 | D | ↗ |
| 2024-11-01 | COZADD BRUCE C | Director / Officer | S-Sale | D | Ordinary Shares | 1,000 | 110.84 | 110.8K | 428,976 | D | ↗ |
| 2024-09-06 | Henderson Mary Elizabeth | Officer | S-Sale | D | Ordinary Shares | 1,410 | 108.30 | 152.7K | 14,531 | — | ↗ |
| 2024-08-06 | Winningham Rick E | Director | F-InKind | D | Ordinary Shares | 1,484 | 111.35 | 165.2K | 12,691 | — | ↗ |
| 2024-08-06 | Smith Mark Douglas | Director | F-InKind | D | Ordinary Shares | 1,484 | 111.35 | 165.2K | 9,135 | — | ↗ |
| 2024-08-06 | RIEDEL NORBERT G | Director | F-InKind | D | Ordinary Shares | 1,484 | 111.35 | 165.2K | 5,322 | — | ↗ |
| 2024-08-06 | ORiordan Anne | Director | F-InKind | D | Ordinary Shares | 1,484 | 111.35 | 165.2K | 14,798 | — | ↗ |
| 2024-08-06 | O'Keefe Kenneth W | Director | F-InKind | D | Ordinary Shares | 1,484 | 111.35 | 165.2K | 26,970 | — | ↗ |
| 2024-08-06 | McSharry Heather Ann | Director | F-InKind | D | Ordinary Shares | 1,608 | 111.35 | 179.1K | 18,901 | — | ↗ |
| 2024-08-06 | Cook Jennifer E. | Director | F-InKind | D | Ordinary Shares | 1,484 | 111.35 | 165.2K | 9,135 | — | ↗ |
| 2024-08-02 | Winningham Rick E | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 14,175 | — | ↗ |
| 2024-08-02 | Smith Mark Douglas | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 10,619 | — | ↗ |
| 2024-08-02 | RIEDEL NORBERT G | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 6,806 | — | ↗ |
| 2024-08-02 | Pearce Samantha | Officer | A-Award | A | Ordinary Shares | 6,996 | 0.00 | — | 24,078 | — | ↗ |
| 2024-08-02 | ORiordan Anne | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 16,282 | — | ↗ |
| 2024-08-02 | O'Keefe Kenneth W | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 28,454 | — | ↗ |
| 2024-08-02 | Mulligan Seamus | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 1,176,106 | — | ↗ |
| 2024-08-02 | McSharry Heather Ann | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 20,509 | — | ↗ |
| 2024-08-02 | Kennedy Patrick | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 5,154 | — | ↗ |
| 2024-08-02 | Hamill Laura | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 5,231 | — | ↗ |
| 2024-08-02 | ENRIGHT PATRICK G | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 24,677 | — | ↗ |
| 2024-08-02 | Cook Jennifer E. | Director | A-Award | A | Ordinary Shares | 3,731 | 0.00 | — | 10,619 | — | ↗ |
| 2024-07-25 | Hamill Laura | Director | — | D | Ordinary Shares | 0 | 0.00 | — | 1,500 | — | ↗ |
| 2024-06-07 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 163 | 108.83 | 17.7K | 6,596 | — | ↗ |
| 2024-05-03 | Patil Neena M | Officer | S-Sale | D | Ordinary Shares | 5,000 | 109.65 | 548.3K | 36,629 | — | ↗ |
| 2024-04-05 | GALA RENEE D | Officer | F-InKind | D | Ordinary Shares | 1,736 | 115.21 | 200.0K | 55,357 | — | ↗ |
| 2024-03-07 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 1,768 | 116.98 | 206.8K | 6,596 | — | ↗ |
| 2024-03-06 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 1,236 | 120.85 | 149.4K | 9,064 | — | ↗ |
| 2024-03-05 | Pearce Samantha | Officer | F-InKind | D | Ordinary Shares | 2,474 | 117.53 | 290.8K | 16,922 | — | ↗ |
| 2024-03-05 | Patil Neena M | Officer | F-InKind | D | Ordinary Shares | 3,432 | 117.53 | 403.4K | 41,629 | — | ↗ |
| 2024-03-05 | Iannone Robert | Officer | F-InKind | D | Ordinary Shares | 4,294 | 117.53 | 504.7K | 62,226 | — | ↗ |
| 2024-03-05 | GALA RENEE D | Officer | F-InKind | D | Ordinary Shares | 3,622 | 117.53 | 425.7K | 57,093 | — | ↗ |
| 2024-03-05 | COZADD BRUCE C | Director / Officer | F-InKind | D | Ordinary Shares | 22,436 | 117.53 | 2.64M | 429,809 | — | ↗ |
| 2024-03-01 | Pearce Samantha | Officer | A-Award | A | Ordinary Shares | 5,065 | 0.00 | — | 19,396 | — | ↗ |
| 2024-03-01 | Patil Neena M | Officer | A-Award | A | Ordinary Shares | 12,348 | 0.00 | — | 45,061 | — | ↗ |
| 2024-03-01 | Kennedy Patrick | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-01 | Johnson Philip L | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-01 | Iannone Robert | Officer | A-Award | A | Ordinary Shares | 16,928 | 0.00 | — | 66,520 | — | ↗ |
| 2024-03-01 | Henderson Mary Elizabeth | Officer | A-Award | A | Ordinary Shares | 5,178 | 0.00 | — | 15,941 | — | ↗ |
| 2024-03-01 | GALA RENEE D | Officer | A-Award | A | Ordinary Shares | 19,916 | 0.00 | — | 60,715 | — | ↗ |
| 2024-03-01 | Carr Patricia | Officer | A-Award | A | Ordinary Shares | 2,987 | 0.00 | — | 10,300 | — | ↗ |
| 2024-03-01 | COZADD BRUCE C | Director / Officer | A-Award | A | Ordinary Shares | 50,187 | 0.00 | — | 452,245 | — | ↗ |
| 2024-01-17 | Pearce Samantha | Officer | F-InKind | D | Ordinary Shares | 1,038 | 119.13 | 123.7K | 14,331 | — | ↗ |
| 2024-01-17 | Patil Neena M | Officer | A-Award | A | Ordinary Shares | 5,087 | 0.00 | — | 34,369 | — | ↗ |
| 2024-01-17 | Iannone Robert | Officer | F-InKind | D | Ordinary Shares | 1,730 | 119.13 | 206.1K | 49,592 | — | ↗ |
| 2024-01-17 | GALA RENEE D | Officer | F-InKind | D | Ordinary Shares | 3,204 | 119.13 | 381.7K | 40,799 | — | ↗ |
| 2024-01-17 | Carr Patricia | Officer | A-Award | A | Ordinary Shares | 1,327 | 0.00 | — | 7,363 | — | ↗ |
| 2024-01-17 | COZADD BRUCE C | Director / Officer | F-InKind | D | Ordinary Shares | 12,245 | 119.13 | 1.46M | 402,058 | — | ↗ |
| 2023-12-31 | Carr Patricia | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-04 | Smith Mark Douglas | Director | S-Sale | D | Ordinary Shares | 417 | 119.27 | 49.7K | 6,888 | — | ↗ |
| 2023-12-04 | Cook Jennifer E. | Director | S-Sale | D | Ordinary Shares | 417 | 119.27 | 49.7K | 6,888 | — | ↗ |
| 2023-11-10 | GALA RENEE D | Officer | A-Award | A | Ordinary Shares | 772 | 0.00 | — | 36,887 | — | ↗ |
| 2023-09-01 | Patil Neena M | Officer | S-Sale | D | Ordinary Shares | 1,500 | 144.25 | 216.4K | 29,186 | — | ↗ |
| 2023-08-29 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 142 | 143.47 | 20.4K | 5,986 | — | ↗ |
| 2023-08-15 | Patil Neena M | Officer | S-Sale | D | Ordinary Shares | 750 | 139.59 | 104.7K | 30,686 | — | ↗ |
| 2023-08-14 | Winningham Rick E | Director | S-Sale | D | Ordinary Shares | 1,241 | 138.16 | 171.5K | 10,444 | — | ↗ |
| 2023-08-14 | Sohn Catherine A. | Director | S-Sale | D | Ordinary Shares | 1,241 | 138.16 | 171.5K | 14,868 | — | ↗ |
| 2023-08-14 | Smith Mark Douglas | Director | S-Sale | D | Ordinary Shares | 1,241 | 138.16 | 171.5K | 7,305 | — | ↗ |
| 2023-08-14 | RIEDEL NORBERT G | Director | S-Sale | D | Ordinary Shares | 1,241 | 138.16 | 171.5K | 13,705 | — | ↗ |
| 2023-08-14 | ORiordan Anne | Director | S-Sale | D | Ordinary Shares | 1,241 | 138.16 | 171.5K | 12,551 | — | ↗ |
| 2023-08-14 | O'Keefe Kenneth W | Director | S-Sale | D | Ordinary Shares | 1,241 | 138.16 | 171.5K | 24,723 | — | ↗ |
| 2023-08-14 | McSharry Heather Ann | Director | S-Sale | D | Ordinary Shares | 1,344 | 138.16 | 185.7K | 16,778 | — | ↗ |
| 2023-08-14 | Gray Peter | Director | S-Sale | D | Ordinary Shares | 1,241 | 138.16 | 171.5K | 16,068 | — | ↗ |
| 2023-08-14 | ENRIGHT PATRICK G | Director | S-Sale | D | Ordinary Shares | 1,241 | 138.16 | 171.5K | 20,946 | — | ↗ |
| 2023-08-14 | Cook Jennifer E. | Director | S-Sale | D | Ordinary Shares | 1,241 | 138.16 | 171.5K | 7,305 | — | ↗ |
| 2023-08-14 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 158 | 138.16 | 21.8K | 6,128 | — | ↗ |
| 2023-08-11 | Winningham Rick E | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 11,685 | — | ↗ |
| 2023-08-11 | Sohn Catherine A. | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 16,109 | — | ↗ |
| 2023-08-11 | Smith Mark Douglas | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 8,546 | — | ↗ |
| 2023-08-11 | RIEDEL NORBERT G | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 14,946 | — | ↗ |
| 2023-08-11 | ORiordan Anne | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 13,792 | — | ↗ |
| 2023-08-11 | O'Keefe Kenneth W | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 25,964 | — | ↗ |
| 2023-08-11 | Mulligan Seamus | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 1,172,375 | — | ↗ |
| 2023-08-11 | McSharry Heather Ann | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 18,122 | — | ↗ |
| 2023-08-11 | Henderson Mary Elizabeth | Officer | A-Award | A | Ordinary Shares | 10,763 | 0.00 | — | 10,763 | — | ↗ |
| 2023-08-11 | Gray Peter | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 17,309 | — | ↗ |
| 2023-08-11 | ENRIGHT PATRICK G | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 22,187 | — | ↗ |
| 2023-08-11 | Cook Jennifer E. | Director | A-Award | A | Ordinary Shares | 3,075 | 0.00 | — | 8,546 | — | ↗ |
| 2023-08-07 | Patil Neena M | Officer | D-Return | D | Ordinary Shares | 1,390 | 131.51 | 182.8K | 31,436 | — | ↗ |
| 2023-08-03 | Henderson Mary Elizabeth | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-08 | Mulligan Seamus | Director | M-Exempt | A | Ordinary Shares | 4,500 | 81.76 | 367.9K | 1,169,300 | — | ↗ |
| 2023-06-07 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 126 | 127.92 | 16.1K | 6,286 | — | ↗ |
| 2023-06-05 | Sablich Kim | Officer | D-Return | D | Ordinary Shares | 2,082 | 129.73 | 270.1K | 28,478 | — | ↗ |
| 2023-06-05 | Iannone Robert | Officer | D-Return | D | Ordinary Shares | 1,311 | 129.73 | 170.1K | 45,315 | — | ↗ |
| 2023-06-01 | Patil Neena M | Officer | S-Sale | D | Ordinary Shares | 1,526 | 127.98 | 195.3K | 32,900 | — | ↗ |
| 2023-05-18 | GALA RENEE D | Officer | S-Sale | D | Ordinary Shares | 6,000 | 131.75 | 790.5K | 35,978 | — | ↗ |
| 2023-04-05 | GALA RENEE D | Officer | F-InKind | D | Ordinary Shares | 1,807 | 145.78 | 263.4K | 41,978 | — | ↗ |
| 2023-03-15 | Carr Patricia | Officer | S-Sale | D | Ordinary Shares | 1,023 | 133.22 | 136.3K | 6,286 | — | ↗ |
| 2023-03-08 | Sablich Kim | Officer | S-Sale | D | Ordinary Shares | 1,752 | 139.42 | 244.3K | 31,821 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-150.0K
Shares Outstanding
62.74M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Bruce C. Cozadd Chairperson and CEO | 1.20M | — | 12.80M | — | 1.49M | 31.8K | 15.53M | 82.43% | ↗ |
| 2 | 2024 | Renée Galá President and COO | 824.9K | — | 5.08M | — | 697.0K | 27.6K | 6.63M | 76.63% | ↗ |
| 3 | 2024 | Robert Iannone, M.D., M.S.C.E Executive Vice President, Global Head of R&D | 750.7K | — | 4.32M | — | 598.0K | 23.4K | 5.69M | 75.88% | ↗ |
| 4 | 2024 | Philip L. Johnson Executive Vice President and CFO | 581.5K | 150.0K | 4.06M | — | 427.0K | 21.6K | 5.24M | 77.49% | ↗ |
| 5 | 2024 | Samantha Pearce Executive Vice President, CCO | 619.8K | 300.0K | 2.98M | — | 491.0K | 77.9K | 4.46M | 66.65% | ↗ |
| 6 | 2024 | Patricia Carr Senior Vice President and CAO (Former Interim Principal Financial Officer) | 430.0K | — | 761.8K | — | 220.7K | 39.7K | 1.45M | 52.46% | ↗ |
| 7 | 2023 | Bruce C. Cozadd Chairperson and CEO | 1.20M | — | 12.90M | — | 1.22M | 30.9K | 15.34M | 84.06% | ↗ |
| 8 | 2023 | Daniel N. Swisher, Jr. Former President and COO | 834.9K | — | 4.09M | — | 570.0K | 30.1K | 5.53M | 74.05% | ↗ |
| 9 | 2023 | Renée Galá President and COO | 767.7K | — | 4.08M | — | 570.0K | 19.3K | 5.43M | 75.03% | ↗ |
| 10 | 2023 | Robert Iannone, M.D., M.S.C.E Executive Vice President, Global Head of R&D | 720.5K | — | 3.79M | — | 450.0K | 21.6K | 4.98M | 76.06% | ↗ |
| 11 | 2023 | Robert Iannone, M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | 720.5K | — | 3.79M | — | 450.0K | 21.6K | 4.98M | 76.06% | ↗ |
| 12 | 2023 | Kim Sablich Former Executive Vice President and General Manager, US | 632.4K | — | 3.17M | — | 326.5K | 33.3K | 4.17M | 76.18% | ↗ |
| 13 | 2023 | Neena M. Patil Executive Vice President and Chief Legal Officer | 673.9K | — | 2.87M | — | 320.0K | 17.8K | 3.88M | 73.91% | ↗ |
| 14 | 2023 | Patricia Carr Senior Vice President and CAO (Former Interim Principal Financial Officer) | 402.2K | — | 767.6K | — | 194.9K | 36.4K | 1.40M | 54.79% | ↗ |
| 15 | 2023 | Patricia Carr Senior Vice President and Chief Accounting Officer (Former Interim Principal Financial Officer) | 402.2K | — | 767.6K | — | 194.9K | 36.4K | 1.40M | 54.79% | ↗ |
| 16 | 2022 | Bruce C. Cozadd Chairperson and CEO | 1.20M | — | 14.87M | — | 1.23M | 20.8K | 17.33M | 85.85% | ↗ |
| 17 | 2022 | Daniel N. Swisher, Jr. Former President and COO | 801.4K | — | 4.49M | — | 639.0K | 27.8K | 5.95M | 75.34% | ↗ |
| 18 | 2022 | Daniel N. Swisher, Jr. President, COO | 801.4K | — | 4.49M | — | 639.0K | 27.8K | 5.95M | 75.34% | ↗ |
| 19 | 2022 | Renée Galá Executive Vice President and CFO | 690.4K | — | 3.90M | — | 430.0K | 13.7K | 5.03M | 77.45% | ↗ |
| 20 | 2022 | Renée Galá President and COO | 690.4K | — | 3.90M | — | 430.0K | 13.7K | 5.03M | 77.45% | ↗ |
| 21 | 2022 | Robert Iannone, M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | 663.7K | — | 3.78M | — | 400.0K | 14.8K | 4.86M | 77.79% | ↗ |
| 22 | 2022 | Robert Iannone, M.D., M.S.C.E Executive Vice President, Global Head of R&D | 663.7K | — | 3.78M | — | 400.0K | 14.8K | 4.86M | 77.79% | ↗ |
| 23 | 2022 | Kim Sablich Former Executive Vice President and General Manager, US | 606.1K | — | 3.31M | — | 370.0K | 21.8K | 4.30M | 76.81% | ↗ |
| 24 | 2022 | Kim Sablich Executive Vice President and General Manager, US | 606.1K | — | 3.31M | — | 370.0K | 21.8K | 4.30M | 76.81% | ↗ |
| 25 | 2021 | Bruce C. Cozadd Chairperson and CEO | 1.08M | — | 13.41M | — | 1.16M | 24.5K | 15.68M | 85.55% | ↗ |
| 26 | 2021 | Daniel N. Swisher, Jr. Former President and COO | 711.2K | — | 4.14M | — | 540.0K | 16.0K | 5.40M | 76.55% | ↗ |
| 27 | 2021 | Daniel N. Swisher, Jr. President | 711.2K | — | 4.14M | — | 540.0K | 16.0K | 5.40M | 76.55% | ↗ |
| 28 | 2021 | Daniel N. Swisher, Jr. President, COO | 711.2K | — | 4.14M | — | 540.0K | 16.0K | 5.40M | 76.55% | ↗ |
| 29 | 2021 | Renée Galá President and COO | 616.9K | — | 3.58M | — | 400.0K | 10.4K | 4.61M | 77.69% | ↗ |
| 30 | 2021 | Renée Galá Executive Vice President and CFO | 616.9K | — | 3.58M | — | 400.0K | 10.4K | 4.61M | 77.69% | ↗ |
| 31 | 2021 | Chris Tovey Executive Vice President and Chief Operating Officer and Managing Director, Europe and International | 366.6K | 297.6K | 3.29M | — | 211.8K | 4.7K | 4.17M | 78.87% | ↗ |
| 32 | 2021 | Robert Iannone, M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | 591.9K | — | 3.02M | — | 380.0K | 11.3K | 4.00M | 75.43% | ↗ |
| 33 | 2021 | Kim Sablich Former Executive Vice President and General Manager, US | 566.9K | — | 3.02M | — | 340.0K | 22.5K | 3.95M | 76.46% | ↗ |
| 34 | 2021 | Kim Sablich Executive Vice President and General Manager, US | 566.9K | — | 3.02M | — | 340.0K | 22.5K | 3.95M | 76.46% | ↗ |
| 35 | 2020 | Bruce C. Cozadd Chairman and CEO | 1.09M | — | 5.88M | 4.21M | 1.38M | 14.9K | 12.57M | 80.26% | ↗ |
| 36 | 2020 | Bruce C. Cozadd Chairperson and CEO | 1.09M | — | 5.88M | 4.21M | 1.38M | 14.9K | 12.57M | 80.26% | ↗ |
| 37 | 2020 | Kim Sablich Executive Vice President and General Manager, North America | 327.9K | 300.0K | 2.13M | 1.62M | 235.0K | 6.6K | 4.62M | 81.19% | ↗ |
| 38 | 2020 | Kim Sablich Executive Vice President and General Manager, US | 327.9K | 300.0K | 2.13M | 1.62M | 235.0K | 6.6K | 4.62M | 81.19% | ↗ |
| 39 | 2020 | Daniel N. Swisher, Jr. President and COO | 713.7K | — | 1.81M | 1.30M | 636.0K | 16.2K | 4.47M | 69.45% | ↗ |
| 40 | 2020 | Daniel N. Swisher, Jr. President | 713.7K | — | 1.81M | 1.30M | 636.0K | 16.2K | 4.47M | 69.45% | ↗ |
| 41 | 2020 | Daniel N. Swisher, Jr. President, COO | 713.7K | — | 1.81M | 1.30M | 636.0K | 16.2K | 4.47M | 69.45% | ↗ |
| 42 | 2020 | Renée Galá Executive Vice President and CFO | 484.6K | 25.0K | 1.82M | 1.38M | 405.0K | 9.9K | 4.12M | 77.58% | ↗ |
| 43 | 2020 | Robert Iannone, M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | 592.3K | — | 1.22M | 874.5K | 450.0K | 11.2K | 3.15M | 66.55% | ↗ |
| 44 | 2020 | Robert Ianonne Executive Vice President, Research and Development and Chief Medical Officer | 592.3K | — | 1.22M | 874.5K | 450.0K | 11.2K | 3.15M | 66.55% | ↗ |
| 45 | 2019 | Bruce C. Cozadd Chairman and CEO | 1.01M | — | 7.00M | 5.38M | 1.30M | 13.3K | 14.71M | 84.15% | ↗ |
| 46 | 2019 | Bruce C. Cozadd Chairperson and CEO | 1.01M | — | 7.00M | 5.38M | 1.30M | 13.3K | 14.71M | 84.15% | ↗ |
| 47 | 2019 | Daniel N. Swisher, Jr. President and COO | 667.3K | — | 1.96M | 1.51M | 560.0K | 13.3K | 4.71M | 73.65% | ↗ |
| 48 | 2019 | Daniel N. Swisher, Jr. President | 667.3K | — | 1.96M | 1.51M | 560.0K | 13.3K | 4.71M | 73.65% | ↗ |
| 49 | 2019 | Robert Iannone Executive Vice President, Research and Development | 313.1K | 205.0K | 1.67M | 1.25M | 245.0K | 8.4K | 3.69M | 79.11% | ↗ |
| 50 | 2019 | Robert Iannone, M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | 313.1K | 205.0K | 1.67M | 1.25M | 245.0K | 8.4K | 3.69M | 79.11% | ↗ |
| 51 | 2019 | Robert Ianonne Executive Vice President, Research and Development and Chief Medical Officer | 313.1K | 205.0K | 1.67M | 1.25M | 245.0K | 8.4K | 3.69M | 79.11% | ↗ |
| 52 | 2019 | Matthew P. Young Former Executive Vice President and CFO | 601.3K | — | 1.68M | 1.29M | — | 10.6K | 3.58M | 82.93% | ↗ |
| 53 | 2019 | Neena M. Patil Senior Vice President and GC | 166.7K | 62.5K | 1.65M | 1.23M | 100.0K | 2.4K | 3.21M | 89.66% | ↗ |
| 54 | 2018 | Bruce C. Cozadd Chairman and CEO | 979.3K | — | 5.20M | 4.27M | 980.3K | 13.2K | 11.44M | 82.76% | ↗ |
| 55 | 2018 | Daniel N. Swisher, Jr. President and COO | 608.2K | 125.0K | 2.53M | 2.08M | 400.0K | 12.9K | 5.75M | 80.08% | ↗ |
| 56 | 2018 | Suzanne Sawochka Hooper Former Executive Vice President and GC | 575.4K | — | 1.32M | 1.08M | 400.0K | 10.9K | 3.39M | 70.93% | ↗ |
| 57 | 2018 | Matthew P. Young Former Executive Vice President and CFO | 575.4K | — | 1.32M | 1.08M | 365.0K | 10.0K | 3.36M | 71.69% | ↗ |
| 58 | 2018 | Matthew P. Young Executive Vice President and CFO | 575.4K | — | 1.32M | 1.08M | 365.0K | 10.0K | 3.36M | 71.69% | ↗ |
| 59 | 2018 | Michael P. Miller Executive Vice President U.S Commercial | 521.2K | — | 1.13M | 922.3K | 275.0K | 15.8K | 2.86M | 71.61% | ↗ |
| 60 | 2017 | Bruce C. Cozadd Chairman and CEO | 950.4K | — | 4.71M | 3.67M | 961.8K | 10.7K | 10.30M | 81.34% | ↗ |
| 61 | 2017 | Suzanne Sawochka Hooper Executive Vice President and GC | 546.2K | — | 1.36M | 1.06M | 350.0K | 10.7K | 3.33M | 72.76% | ↗ |
| 62 | 2017 | Suzanne Sawochka Hooper Former Executive Vice President and GC | 546.2K | — | 1.36M | 1.06M | 350.0K | 10.7K | 3.33M | 72.76% | ↗ |
| 63 | 2017 | Matthew P. Young Former Executive Vice President and CFO | 545.4K | — | 1.36M | 1.06M | 315.0K | 9.8K | 3.29M | 73.57% | ↗ |
| 64 | 2017 | Matthew P. Young Executive Vice President and CFO | 545.4K | — | 1.36M | 1.06M | 315.0K | 9.8K | 3.29M | 73.57% | ↗ |
| 65 | 2017 | Russell J. Cox Former Executive Vice President and COO | 587.7K | — | 1.36M | 1.06M | 162.0K | 10.7K | 3.18M | 76.11% | ↗ |
| 66 | 2017 | Karen Smith, M.D., Ph.D. Former Executive Vice President, Research and Development, CMO | 516.9K | — | 1.18M | 915.9K | 287.7K | 10.7K | 2.91M | 71.96% | ↗ |
| 67 | 2017 | Michael P. Miller Executive Vice President U.S Commercial | 492.3K | — | 1.18M | 915.9K | 270.0K | 15.6K | 2.87M | 72.90% | ↗ |
| 68 | 2016 | Bruce C. Cozadd Chairman and CEO | 917.3K | — | 3.82M | 3.11M | 914.6K | 5.6K | 8.77M | 79.05% | ↗ |
| 69 | 2016 | Russell J. Cox Executive Vice President and COO | 571.2K | — | 1.11M | 902.7K | 313.2K | 5.6K | 2.90M | 69.34% | ↗ |
| 70 | 2016 | Russell J. Cox Former Executive Vice President and COO | 571.2K | — | 1.11M | 902.7K | 313.2K | 5.6K | 2.90M | 69.34% | ↗ |
| 71 | 2016 | Suzanne Sawochka Hooper Executive Vice President and GC | 521.2K | — | 1.11M | 902.7K | 300.0K | 5.6K | 2.84M | 70.89% | ↗ |
| 72 | 2016 | Suzanne Sawochka Hooper Former Executive Vice President and GC | 521.2K | — | 1.11M | 902.7K | 300.0K | 5.6K | 2.84M | 70.89% | ↗ |
| 73 | 2016 | Matthew P. Young Executive Vice President and CFO | 513.1K | — | 1.11M | 902.7K | 300.0K | 4.7K | 2.83M | 71.11% | ↗ |
| 74 | 2016 | Karen Smith, M.D., Ph.D. Executive Vice President, Research & Development and CMO | 496.2K | — | 740.2K | 601.8K | 245.0K | 4.7K | 2.09M | 64.28% | ↗ |
| 75 | 2016 | Karen Smith, M.D., Ph.D. Former Executive Vice President, Research and Development, CMO | 496.2K | — | 740.2K | 601.8K | 245.0K | 4.7K | 2.09M | 64.28% | ↗ |
| 76 | 2016 | Michael P. Miller Executive Vice President U.S Commercial | 446.9K | — | 740.2K | 601.8K | 225.0K | 7.9K | 2.02M | 66.37% | ↗ |
| 77 | 2015 | Bruce C. Cozadd Chairman and CEO | 869.6K | — | 4.87M | 4.18M | 750.5K | 4.6K | 10.68M | 84.78% | ↗ |
| 78 | 2015 | Bruce C. Cozadd Chairman and Chief Executive Officer | 869.6K | — | 4.87M | 4.18M | 750.5K | 4.6K | 10.68M | 84.78% | ↗ |
| 79 | 2015 | Russell J. Cox Executive Vice President and Chief Operating Officer | 546.2K | — | 1.34M | 1.15M | 255.0K | 4.6K | 3.30M | 75.61% | ↗ |
| 80 | 2015 | Russell J. Cox Executive Vice President and COO | 546.2K | — | 1.34M | 1.15M | 255.0K | 4.6K | 3.30M | 75.61% | ↗ |
| 81 | 2015 | Russell J. Cox Former Executive Vice President and COO | 546.2K | — | 1.34M | 1.15M | 255.0K | 4.6K | 3.30M | 75.61% | ↗ |
| 82 | 2015 | Suzanne Sawochka Hooper Executive Vice President and GC | 497.7K | — | 1.34M | 1.15M | 240.0K | 4.6K | 3.24M | 77.09% | ↗ |
| 83 | 2015 | Suzanne Sawochka Hooper Executive Vice President and General Counsel | 497.7K | — | 1.34M | 1.15M | 240.0K | 4.6K | 3.24M | 77.09% | ↗ |
| 84 | 2015 | Matthew P. Young Executive Vice President and CFO | 465.8K | — | 1.34M | 1.15M | 225.0K | 3.7K | 3.19M | 78.25% | ↗ |
| 85 | 2015 | Matthew P. Young Executive Vice President and Chief Financial Officer | 465.8K | — | 1.34M | 1.15M | 225.0K | 3.7K | 3.19M | 78.25% | ↗ |
| 86 | 2015 | Karen Smith, M.D., Ph.D. Former Executive Vice President, Research and Development, CMO | 338.0K | 290.0K | 1.25M | 1.03M | 130.0K | 67.5K | 3.11M | 73.49% | ↗ |
| 87 | 2015 | Karen Smith, M.D., Ph.D. Global Head of Research and Development and Chief Medical Officer | 338.0K | 290.0K | 1.25M | 1.03M | 130.0K | 67.5K | 3.11M | 73.49% | ↗ |
| 88 | 2015 | Karen Smith, M.D., Ph.D. Executive Vice President, Research & Development and CMO | 338.0K | 290.0K | 1.25M | 1.03M | 130.0K | 67.5K | 3.11M | 73.49% | ↗ |
| 89 | 2014 | Bruce C. Cozadd Chairman and Chief Executive Officer | 830.0K | — | 5.50M | 4.19M | 1.02M | 11.7K | 11.56M | 83.88% | ↗ |
| 90 | 2014 | Bruce C. Cozadd Chairman and CEO | 830.0K | — | 5.50M | 4.19M | 1.02M | 11.7K | 11.56M | 83.88% | ↗ |
| 91 | 2014 | Bruce C. Cozadd Chairman and Chief Executive Officer | 830.0K | — | 5.50M | 4.19M | 1.02M | 11.7K | 11.56M | 83.88% | ↗ |
| 92 | 2014 | Russell J. Cox Executive Vice President and Chief Operating Officer | 493.5K | — | 2.68M | 1.99M | 320.0K | 11.8K | 5.50M | 84.99% | ↗ |
| 93 | 2014 | Russell J. Cox Executive Vice President and Chief Operating Officer | 493.5K | — | 2.68M | 1.99M | 320.0K | 11.8K | 5.50M | 84.99% | ↗ |
| 94 | 2014 | Russell J. Cox Executive Vice President and COO | 493.5K | — | 2.68M | 1.99M | 320.0K | 11.8K | 5.50M | 84.99% | ↗ |
| 95 | 2014 | Suzanne Sawochka Hooper Executive Vice President and General Counsel | 483.5K | — | 1.67M | 1.27M | 320.0K | 3.7K | 3.74M | 78.44% | ↗ |
| 96 | 2014 | Suzanne Sawochka Hooper Executive Vice President and General Counsel | 483.5K | — | 1.67M | 1.27M | 320.0K | 3.7K | 3.74M | 78.44% | ↗ |
| 97 | 2014 | Suzanne Sawochka Hooper Executive Vice President and GC | 483.5K | — | 1.67M | 1.27M | 320.0K | 3.7K | 3.74M | 78.44% | ↗ |
| 98 | 2014 | Matthew P. Young Executive Vice President and Chief Financial Officer | 402.9K | — | 1.56M | 1.19M | 250.0K | 3.6K | 3.41M | 80.72% | ↗ |
| 99 | 2014 | Matthew P. Young Executive Vice President and CFO | 402.9K | — | 1.56M | 1.19M | 250.0K | 3.6K | 3.41M | 80.72% | ↗ |
| 100 | 2014 | Michael P. Miller Executive Vice President U.S Commercial | 266.2K | 30.0K | 1.42M | 1.07M | 140.0K | 4.6K | 2.93M | 84.96% | ↗ |
| 101 | 2014 | Kathryn E. Falberg Former Executive Vice President and Chief Financial Officer | 136.9K | — | — | — | — | 7.5K | 144.4K | 0.00% | ↗ |
| 102 | 2013 | Bruce C. Cozadd Chairman and Chief Executive Officer | 771.2K | — | 2.96M | 3.48M | 1.06M | 3.6K | 8.27M | 77.85% | ↗ |
| 103 | 2013 | Bruce C. Cozadd Chairman and Chief Executive Officer | 771.2K | — | 2.96M | 3.48M | 1.06M | 3.6K | 8.27M | 77.85% | ↗ |
| 104 | 2013 | Suzanne Sawochka Hooper Executive Vice President and General Counsel | 473.5K | 62.5K | 946.1K | 890.6K | 430.0K | 2.7K | 2.81M | 65.47% | ↗ |
| 105 | 2013 | Suzanne Sawochka Hooper Executive Vice President and General Counsel | 473.5K | 62.5K | 946.1K | 890.6K | 430.0K | 2.7K | 2.81M | 65.47% | ↗ |
| 106 | 2013 | Kathryn E. Falberg Former Executive Vice President and Chief Financial Officer | 472.7K | — | 946.1K | 890.6K | 380.0K | 3.6K | 2.69M | 68.20% | ↗ |
| 107 | 2013 | Russell J. Cox Executive Vice President and Chief Operating Officer | 419.6K | — | 813.0K | 765.3K | 380.0K | 3.6K | 2.38M | 66.27% | ↗ |
| 108 | 2013 | Russell J. Cox Executive Vice President and Chief Operating Officer | 419.6K | — | 813.0K | 765.3K | 380.0K | 3.6K | 2.38M | 66.27% | ↗ |
| 109 | 2013 | Fintan Keegan | 356.7K | — | 739.1K | 695.8K | 260.0K | 27.3K | 2.08M | 69.02% | ↗ |
| 110 | 2012 | Bruce C. Cozadd Chairman and Chief Executive Officer | 722.2K | — | 4.68M | 4.63M | 1.08M | 1.7K | 11.12M | 83.76% | ↗ |
| 111 | 2012 | Suzanne Sawochka Hooper Executive Vice President and General Counsel | 420.3K | 187.5K | 1.64M | 1.62M | 350.0K | 1.5K | 4.22M | 77.26% | ↗ |
| 112 | 2012 | Suzanne Sawochka Hooper Executive Vice President and General Counsel | 420.3K | 187.5K | 1.64M | 1.62M | 350.0K | 1.5K | 4.22M | 77.26% | ↗ |
| 113 | 2012 | Kathryn E. Falberg Former Executive Vice President and Chief Financial Officer | 446.8K | — | 1.64M | 1.62M | 390.0K | 2.6K | 4.10M | 79.52% | ↗ |
| 114 | 2012 | Kathryn E. Falberg Executive Vice President and Chief Financial Officer | 446.8K | — | 1.64M | 1.62M | 390.0K | 2.6K | 4.10M | 79.52% | ↗ |
| 115 | 2012 | Jeffrey K. Tobias, M.D. | 422.0K | 125.0K | 1.64M | 1.62M | 250.0K | 4.5K | 4.06M | 80.26% | ↗ |
| 116 | 2012 | Russell J. Cox Executive Vice President and Chief Commercial Officer | 379.3K | — | 1.64M | 1.62M | 300.0K | 1.6K | 3.94M | 82.72% | ↗ |
| 117 | 2012 | Russell J. Cox Executive Vice President and Chief Operating Officer | 379.3K | — | 1.64M | 1.62M | 300.0K | 1.6K | 3.94M | 82.72% | ↗ |
| 118 | 2011 | Bruce C. Cozadd Chairman and Chief Executive Officer | 563.2K | — | — | — | 552.0K | 1.7K | 3.59M | 0.00% | ↗ |
| 119 | 2011 | Bruce C. Cozadd Chairman and Chief Executive Officer | 563.2K | — | — | 2.47M | 552.0K | 1.7K | 3.59M | 68.90% | ↗ |
| 120 | 2011 | Kathryn E. Falberg Executive Vice President and Chief Financial Officer | 377.6K | — | — | 707.1K | 300.0K | 2.3K | 1.39M | 50.98% | ↗ |
| 121 | 2011 | Kathryn E. Falberg Former Executive Vice President and Chief Financial Officer | 377.6K | — | — | — | 300.0K | 2.3K | 1.39M | 0.00% | ↗ |
| 122 | 2011 | Kathryn E. Falberg Executive Vice President and Chief Financial Officer | 377.6K | — | — | 707.1K | 300.0K | 2.3K | 1.39M | 50.98% | ↗ |
| 123 | 2011 | Russell J. Cox Executive Vice President and Chief Commercial Officer | 322.6K | — | — | 707.1K | 225.0K | 1.1K | 1.26M | 56.31% | ↗ |
| 124 | 2011 | Russell J. Cox Executive Vice President and Chief Operating Officer | 322.6K | — | — | — | 225.0K | 1.1K | 1.26M | 0.00% | ↗ |
| 125 | 2011 | Russell J. Cox Executive Vice President and Chief Commercial Officer | 322.6K | — | — | 707.1K | 225.0K | 1.1K | 1.26M | 56.31% | ↗ |
| 126 | 2011 | Karen J. Wilson | 235.0K | — | — | 883.9K | 125.0K | 776.00 | 1.24M | 71.01% | ↗ |
| 127 | 2011 | Carol A. Gamble Former Senior Vice President and General Counsel | 361.8K | — | — | 618.7K | 250.0K | 4.8K | 1.24M | 50.08% | ↗ |
| 128 | 2010 | Bruce C. Cozadd Chairman and Chief Executive Officer | 496.9K | — | — | 1.16M | 267.3K | 1.4K | 1.93M | 60.31% | ↗ |
| 129 | 2010 | Bruce C. Cozadd Chairman and Chief Executive Officer | 496.9K | — | — | 1.16M | 267.3K | 1.4K | 1.93M | 60.31% | ↗ |
| 130 | 2010 | Robert M. Myers President | 449.1K | 224.0K | — | 623.3K | — | 1.4K | 1.30M | 48.03% | ↗ |
| 131 | 2010 | Kathryn E. Falberg Executive Vice President and Chief Financial Officer | 366.4K | 30.0K | — | 498.6K | 150.0K | 1.1K | 1.05M | 47.66% | ↗ |
| 132 | 2010 | Kathryn E. Falberg Executive Vice President and Chief Financial Officer | 366.4K | 30.0K | — | 498.6K | 150.0K | 1.1K | 1.05M | 47.66% | ↗ |
| 133 | 2010 | Kathryn E. Falberg Senior Vice President and Chief Financial Officer | 366.4K | 30.0K | — | 498.6K | 150.0K | 1.1K | 1.05M | 47.66% | ↗ |
| 134 | 2010 | Carol A. Gamble Former Senior Vice President and General Counsel | 361.8K | — | — | 332.4K | 130.0K | 1.1K | 825.3K | 40.28% | ↗ |
| 135 | 2009 | Bruce C. Cozadd Chairman and Chief Executive Officer | 442.7K | — | — | 189.3K | 205.3K | 1.6K | 838.9K | 22.56% | ↗ |
| 136 | 2009 | Robert M. Myers President | 420.0K | — | — | 141.9K | 193.9K | 1.6K | 757.4K | 18.74% | ↗ |
| 137 | 2009 | Kathryn E. Falberg Executive Vice President and Chief Financial Officer | 32.3K | — | — | 526.9K | — | — | 559.2K | 94.23% | ↗ |
| 138 | 2009 | Carol A. Gamble Senior Vice President, General Counsel and Corporate Secretary | 348.0K | — | — | 75.7K | 120.4K | 1.3K | 545.5K | 13.88% | ↗ |
| 139 | 2009 | Carol A. Gamble Former Senior Vice President and General Counsel | 348.0K | — | — | 75.7K | 120.4K | 1.3K | 545.5K | 13.88% | ↗ |
| 140 | 2009 | Samuel R. Saks, M.D. Former Chief Executive Officer | 141.4K | — | — | 189.3K | — | 520.00 | 331.2K | 57.15% | ↗ |
| 141 | 2008 | Samuel R. Saks, M.D. Former Chief Executive Officer | 468.3K | — | — | 490.2K | — | 1.5K | 960.0K | 51.06% | ↗ |
| 142 | 2008 | Bruce C. Cozadd Chairman and Chief Executive Officer | 423.5K | — | — | 490.2K | — | 1.4K | 915.2K | 53.57% | ↗ |
| 143 | 2008 | Robert M. Myers President | 444.1K | — | — | 345.2K | — | 1.5K | 790.8K | 43.66% | ↗ |
| 144 | 2008 | Samuel R. Saks, M.D . Former Chief Executive Officer | 468.3K | — | — | 224.1K | — | 1.5K | 693.9K | 32.29% | ↗ |
| 145 | 2008 | Carol A. Gamble Senior Vice President, General Counsel and Corporate Secretary | 357.3K | — | — | 207.1K | — | 1.2K | 565.7K | 36.62% | ↗ |
| 146 | 2008 | Matthew K. Fust Former Chief Financial Officer | 408.0K | — | — | 111.3K | — | 1.2K | 520.6K | 21.39% | ↗ |
| 147 | 2007 | Samuel R. Saks, M.D. Chief Executive Officer | 443.4K | — | — | 651.6K | 140.0K | 689.00 | 1.24M | 52.73% | ↗ |
| 148 | 2007 | Samuel R. Saks, M.D . Former Chief Executive Officer | 443.4K | — | — | 651.6K | 140.0K | 689.00 | 1.24M | 52.73% | ↗ |
| 149 | 2007 | Robert M. Myers President | 423.4K | — | — | 641.4K | 140.0K | 689.00 | 1.21M | 53.21% | ↗ |
| 150 | 2007 | Bruce C. Cozadd Executive Chairman | 355.3K | — | — | 651.6K | 115.0K | 521.00 | 1.12M | 58.05% | ↗ |
| 151 | 2007 | Bruce C. Cozadd Chairman and Chief Executive Officer | 355.3K | — | — | 651.6K | 115.0K | 521.00 | 1.12M | 58.05% | ↗ |
| 152 | 2007 | Matthew K. Fust Former Chief Financial Officer | 340.9K | — | — | 256.7K | 100.0K | 554.00 | 698.1K | 36.77% | ↗ |
| 153 | 2007 | Matthew K. Fust Executive Vice President and Chief Financial Officer | 340.9K | — | — | 256.7K | 100.0K | 554.00 | 698.1K | 36.77% | ↗ |
| 154 | 2007 | Carol A. Gamble Senior Vice President, General Counsel and Corporate Secretary | 340.9K | — | — | 257.3K | 95.0K | 554.00 | 693.7K | 37.09% | ↗ |
| 155 | 2007 | Carol A. Gamble Senior Vice President, General Counsel and Corporate Secretary | 340.9K | — | — | 257.3K | 95.0K | 554.00 | 693.7K | 37.09% | ↗ |
| 156 | 2006 | Robert M. Myers President | 406.9K | — | — | — | 120.0K | 234.00 | 1.13M | 0.00% | ↗ |
| 157 | 2006 | Samuel R. Saks, M.D . Former Chief Executive Officer | 406.9K | — | — | — | 102.0K | 234.00 | 1.11M | 0.00% | ↗ |
| 158 | 2006 | Samuel R. Saks, M.D. Chief Executive Officer | 406.9K | — | — | 605.8K | 102.0K | 234.00 | 1.11M | 54.34% | ↗ |
| 159 | 2006 | Bruce C. Cozadd Chairman and Chief Executive Officer | 307.2K | — | — | — | 77.0K | 234.00 | 990.3K | 0.00% | ↗ |
| 160 | 2006 | Bruce C. Cozadd Executive Chairman | 307.2K | — | — | 605.8K | 77.0K | 234.00 | 990.3K | 61.18% | ↗ |
| 161 | 2006 | Carol A. Gamble Senior Vice President, General Counsel and Corporate Secretary | 327.2K | — | — | 231.3K | 80.0K | 234.00 | 638.7K | 36.21% | ↗ |
| 162 | 2006 | Carol A. Gamble Senior Vice President, General Counsel and Corporate Secretary | 327.2K | — | — | 231.3K | 80.0K | 234.00 | 638.7K | 36.21% | ↗ |
| 163 | 2006 | Matthew K. Fust Executive Vice President and Chief Financial Officer | 327.2K | — | — | 231.3K | 70.0K | 234.00 | 628.7K | 36.79% | ↗ |
| 164 | 2006 | Matthew K. Fust Former Chief Financial Officer | 327.2K | — | — | — | 70.0K | 234.00 | 628.7K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Renee D. Gala | President, Chief Executive Officer & Director | 3M | female |
| Bruce C. Cozadd | Co-Founder & Chairman | 2M | male |
| Robert Iannone | Executive Vice President, Chief Medical Officer and Global Head of Research & Development | 2M | — |
| Philip L. Johnson | Executive Vice President & Chief Financial Officer | 1M | male |
| Neena Patil | Executive Vice President & Chief Legal Officer | 1M | female |
| Samantha Pearce | Executive Vice President & Chief Commercial Officer | 1M | female |
| Patricia Carr | Senior Vice President & Chief Accounting Officer | 690.4K | female |
| John Miller | Senior Vice President of Corporate Strategy | — | male |
| Mary Elizabeth Henderson | Senior Vice President of Technical Operations | — | female |
| Jack W. Spinks | Executive Director of Investor Relations | — | — |
| Heidi Manna | Executive Vice President & Chief People Officer | — | female |
| George Christopher Eliades | Senior Vice President & Chief Transformation Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2023-07-12 | 2023-08-13 | Daniel Goldman | NY10 | — | Sale | $15,001 - $50,000 | ↗ |
| 2023-05-19 | 2023-06-12 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2023-03-14 | 2023-04-07 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-03-06 | 2023-04-17 | Daniel Goldman | NY10 | — | Purchase | $15,001 - $50,000 | ↗ |
| 2023-01-31 | 2023-02-24 | Daniel Goldman | NY10 | — | Sale | $1,001 - $15,000 | ↗ |
| 2022-09-26 | 2022-10-14 | Thomas Suozzi | NY03 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2021-10-19 | 2021-11-05 | Thomas Suozzi | NY03 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2019-07-15 | 2019-08-12 | Bill Flores | TX17 | — | Purchase | $15,001 - $50,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for JAZZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
